Reducing CPAP treatment abandonment | Leading home respiratory care provider

Summary

A leading gas therapy company implemented Tucuvi’s clinical AI agent, LOLA, to streamline the follow-up for CPAP therapy, an essential treatment often discontinued by patients due to discomfort in the first 30 days. Traditionally, preventing dropout requires manual, personalized follow-up by clinical teams. The implementation of LOLA led to a 10.5% reduction in the patient dropout rate compared to the period before LOLA, resulting in a treatment adherence rate exceeding 98%. Furthermore, the autonomous follow-up system saved 18 hours of nursing time per week, redirecting valuable clinical capacity from manual calls to more complex patient needs.

Impact